Selected Publications
(See all .)
Sutter, J., Bruggeman, P.J., Wigdahl, B., Krebs, F.C., and Miller, V.
Int J Mol Sci 24. (2023)
Sutter, J., Brettschneider, J., Mamchur, S., Krebs, F., Gershman, S., and Miller, V.
Plasma 6, 577-591 (2023)
Mohamed, H., Berman, R., Connors, J., Haddad, E.K., Miller, V., Nonnemacher, M.R., Dampier, W., Wigdahl, B., and Krebs, F.C.
Biomedicines 11 (2023)
Mohamed, H., Nayak, G., Rendine, N., Wigdahl, B., Krebs, F.C., Bruggeman, P.J., and Miller, V.
Frontiers in Physics 9 (2021)
Mohamed, H., Gebski, E., Reyes, R., Beane, S., Wigdahl, B., Krebs, F.C., Stapelmann, K., and Miller, V.
Cancers (Basel) 13 (2021)
Mohamed, H., Clemen, R., Freund, E., Lackmann, J.W., Wende, K., Connors, J., Haddad, E.K., Dampier, W., Wigdahl, B., Miller, V., Bekeschus, S., and Krebs, F.C.
PLoS One 16, e0247125 (2021)
Ranieri, P., Mohamed, H., Myers, B., Dobossy, L., Beyries, K., Trosan, D., Krebs, F.C., Miller, V., and Stapelmann, K.
Applied Sciences 10 (2020)
Mohamed, H., Miller, V., Jennings, S.R., Wigdahl, B., and Krebs, F.C.
J Immunol Res 2020, 9470102 (2020)
Mohamed, H., Esposito, R.A., Kutzler, M.A., Wigdahl, B., Krebs, F.C., and Miller, V.
Plasma Process Polym 17, 2000051 (2020)
Khalili, M., Daniels, L., Lin, A., Krebs, F.C., Snook, A.E., Bekeschus, S., Bowne, W.B., and Miller, V.
J Phys D Appl Phys 52 (2019)
“Apical Application of “Nanosecond-pulsed dielectric barrier discharge plasma causes the basolateral release of adenosine triphosphate as a damage-associated molecular pattern from polarized HaCaT cells”
Truong B, K Siegert, A Lin, V Miller, and FC Krebs
Plasma Medicine, 7: 117-131, 2017
“Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status”
Dampier W, GC Antell, B Aiamkitsumrit, MR Nonnemacher, JM Jacobson, V Pirrone, W Zhong, K Kercher, S Passic, JW Williams, T James, KN Devlin, T Giovannetti, DJ Libon, Z Szep, GD Ehrlich, B Wigdahl, and FC Krebs
J Neurovirol, 23:113-124, 2017
“Evidence of divergent amino acid usage in comparative analyses of R5- and X4-associated HIV-1 Vpr sequences”
Antell GC, W Dampier, B Aiamkitsumrit, MR Nonnemacher, V Pirrone, W Zhong, K Kercher, S Passic, J Williams, Y Liu, T James, JM Jacobson, Z Szep, B Wigdahl, and FC Krebs
Int J Genomics, 2017:4081585, 2017
“Variability in human semen content and its potential effects in the female reproductive tract”
Keogan S, K Siegert, B Wigdahl, and FC Krebs
Journal of Reproductive Biology and Health, 4: 1, 2016
“Defining the roles for Vpr in HIV-1-associated neuropathogenesis”
James T, MR Nonnemacher, B Wigdahl, and FC Krebs
J Neurovirol, 22:403-415, 2016
“cAMP signaling enhances HIV-1 long terminal repeat (LTR)-directed transcription and viral replication in bone marrow progenitor cells”
Banerjee A, L Li, V Pirrone, FC Krebs, B Wigdahl, and MR Nonnemacher
Clin Med Insights Pathol,10: 1179555717694535, 2016
“Utilization of HIV-1 envelope V3 to identify X4- and R5-specific Tat and LTR sequence signatures”
Antell GC, W Dampier, B Aiamkitsumrit, MR Nonnemacher, JM Jacobson, V Pirrone, W Zhong, K Kercher, S Passic, JW Williams, G Schwartz, U Hershberg, FC Krebs, and B Wigdahl
Retrovirology, 13: 32, 2016
“Critical Review: Immunomodulation by seminal factors and implications for male-to-female HIV-1 transmission
Keogan S, K Siegert, B Wigdahl, and FC Krebs
J Acquir Immune Defic Syndr, 69:131-137, 2015